Clinical Trial Update: Lung Lavage With Dilute Poractant Alfa for Meconium Aspiration Syndrome [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating lung lavage with dilute poractant alfa for Meconium Aspiration Syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meconium Aspiration Syndrome

Drugs mentioned

• Curosurf (poractant alfa)

Snippet

Sponsor: Zekai Tahir Burak Women's Health Research and Education Hospital | Conditions: Meconium Aspiration Syndrome | Phase 4 | Status: COMPLETED